Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navigator: EXPD-101 in COPD
NCT07684820Phase 2Recruiting
- Sponsor
- Expedition Therapeutics
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 4
01
Overview
A Phase 2 trial of XH-S004 in chronic obstructive pulmonary disease (COPD), sponsored by Expedition Therapeutics. Started Jun 2026; status: recruiting.
02
Drugs
XH-S004
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07684820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684820.